Vadivarhe Speciality Chemicals Ltd

Vadivarhe Speciality Chemicals Ltd witnessed a sharp decline on 4 Mar 2026, hitting its lower circuit price limit of ₹24.15, marking a maximum daily loss of 4.92%. The stock’s plunge reflects intense selling pressure and panic among investors, with unfilled supply dominating the trading session.

Vadivarhe Speciality Chemicals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 September 2024. However, the analysis and financial metrics presented here reflect the stock’s current position as of 11 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Vadivarhe Speciality Chemicals Ltd, a micro-cap player in the Chemicals & Petrochemicals sector, surged to hit its upper circuit price limit on 5 Feb 2026, registering a maximum daily gain of 4.92%. This sharp rally was driven by robust buying interest, resulting in a price rise to ₹22.40, the highest and closing price of the day, signalling intense demand despite the stock’s strong sell rating and regulatory trading freeze.

Vadivarhe Speciality Chemicals Ltd surged to its upper circuit limit on 30 Jan 2026, registering a maximum daily gain of 4.91% to close at ₹21.35. This sharp rally was driven by robust buying interest, resulting in a regulatory freeze on further trades and signalling unfilled demand among investors.

Vadivarhe Speciality Chemicals Ltd surged to its upper circuit limit on 27 Jan 2026, registering a maximum daily gain of 4.93% to close at ₹22.35. The stock’s sharp rise was driven by robust buying interest, resulting in a regulatory freeze on further transactions and highlighting unfilled demand in the market.

Vadivarhe Speciality Chemicals Ltd witnessed a sharp decline on 23 Jan 2026, hitting its lower circuit limit as panic selling gripped investors. The stock plunged by 4.91%, underperforming its sector and broader market benchmarks, reflecting intense selling pressure and unfilled supply in the micro-cap chemicals space.

Vadivarhe Speciality Chemicals Ltd surged to its upper circuit limit on 12 Jan 2026, registering a maximum daily gain of 4.9% as robust buying interest propelled the stock to close at ₹20.35. This notable price action occurred despite a subdued sector and broader market performance, highlighting focused investor enthusiasm in this micro-cap chemical player.

Vadivarhe Speciality Chemicals Ltd witnessed a robust surge on 9 Jan 2026, hitting its upper circuit limit with a maximum daily gain of 4.86%, driven by intense buying interest despite subdued trading volumes. The stock closed at ₹19.40, marking a significant outperformance against its sector and the broader market indices.

Vadivarhe Speciality Chemicals Ltd surged to its upper circuit limit on 5 Jan 2026, registering a maximum daily gain of 4.82% to close at ₹18.50. This sharp rise was driven by robust buying interest, with the stock outperforming its sector and broader market indices despite its micro-cap status and recent negative analyst sentiment.

Vadivarhe Speciality Chemicals Ltd, a micro-cap player in the Chemicals & Petrochemicals sector, surged to hit its upper circuit limit on 31 Dec 2025, registering a maximum daily gain of 4.75%. This sharp price movement was driven by robust buying interest, signalling heightened investor enthusiasm despite the company’s current strong sell rating and modest market capitalisation of ₹22.00 crores.

Vadivarhe Speciality Chemicals Ltd, a micro-cap player in the Chemicals & Petrochemicals sector, surged to hit its upper circuit limit on 30 Dec 2025, registering a maximum daily gain of 4.98%. This sharp price movement was driven by robust buying interest, despite the stock trading below all key moving averages, signalling a complex market sentiment.

Vadivarhe Speciality Chemicals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 25 September 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s performance and outlook.

Vadivarhe Speciality Chemicals Ltd witnessed a sharp decline on 18 Dec 2025, hitting its lower circuit price limit of ₹16.65. The stock faced intense selling pressure, resulting in a maximum daily loss of 4.86%, significantly underperforming its sector and broader market indices. This movement reflects heightened investor caution and unfilled supply weighing on the micro-cap chemical company’s shares.

Vadivarhe Speciality Chemicals Ltd witnessed a significant surge in trading activity on 17 Dec 2025, hitting its upper circuit limit of 17.50 rupees. This movement reflects robust buying interest in the stock, which outperformed its sector and broader market indices despite subdued investor participation and liquidity constraints.

Vadivarhe Speciality Chemicals Ltd witnessed a sharp decline on 16 Dec 2025, hitting its lower circuit price limit of ₹16.7, marking a significant daily loss of 4.84%. The stock’s performance notably lagged behind its sector and the broader market, reflecting intense selling pressure and a marked reduction in investor participation.

Vadivarhe Speciality Chemicals Ltd witnessed a sharp decline on 15 Dec 2025, hitting its lower circuit price limit of ₹17.55, marking a maximum daily loss of 4.88%. The stock’s performance notably lagged behind its sector and benchmark indices, reflecting intense selling pressure and unfilled supply on the trading floor.

Vadivarhe Speciality Chemicals Ltd witnessed a sharp decline on 12 Dec 2025, hitting its lower circuit price limit of ₹18.45, marking a new 52-week low. The stock faced intense selling pressure, resulting in a maximum daily loss of 4.9%, significantly underperforming its sector and broader market benchmarks.

Vadivarhe Speci., a microcap player in the Chemicals & Petrochemicals sector, has experienced a notable revision in its market evaluation, reflecting shifts across multiple analytical parameters. This adjustment highlights ongoing challenges in the company’s financial health, valuation outlook, and technical positioning, underscoring the importance of closely monitoring such metrics for informed investment decisions.